ALDR
Bank of America’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-97,105
| Closed | -$1.83M | – | 6695 |
|
|
2019
Q3 | $1.83M | Sell |
97,105
-138,144
| -59% | -$2.61M | ﹤0.01% | 3506 |
|
|
2019
Q2 | $2.77M | Sell |
235,249
-23,404
| -9% | -$275K | ﹤0.01% | 3230 |
|
|
2019
Q1 | $3.53M | Buy |
258,653
+239,005
| +1,216% | +$3.26M | ﹤0.01% | 3021 |
|
|
2018
Q4 | $201K | Buy |
19,648
+8,252
| +72% | +$84.4K | ﹤0.01% | 4794 |
|
|
2018
Q3 | $189K | Sell |
11,396
-521,247
| -98% | -$8.64M | ﹤0.01% | 4813 |
|
|
2018
Q2 | $8.42M | Sell |
532,643
-21,819
| -4% | -$345K | ﹤0.01% | 2282 |
|
|
2018
Q1 | $7.04M | Buy |
554,462
+428,854
| +341% | +$5.45M | ﹤0.01% | 2398 |
|
|
2017
Q4 | $1.44M | Buy |
125,608
+8,641
| +7% | +$98.9K | ﹤0.01% | 3606 |
|
|
2017
Q3 | $1.43M | Sell |
116,967
-4,118
| -3% | -$50.5K | ﹤0.01% | 3641 |
|
|
2017
Q2 | $1.39M | Sell |
121,085
-62,432
| -34% | -$715K | ﹤0.01% | 3609 |
|
|
2017
Q1 | $3.82M | Buy |
183,517
+28,999
| +19% | +$603K | ﹤0.01% | 2823 |
|
|
2016
Q4 | $3.21M | Buy |
154,518
+1,717
| +1% | +$35.7K | ﹤0.01% | 2853 |
|
|
2016
Q3 | $5.01M | Sell |
152,801
-4,150
| -3% | -$136K | ﹤0.01% | 2401 |
|
|
2016
Q2 | $3.92M | Buy |
156,951
+37,722
| +32% | +$942K | ﹤0.01% | 2528 |
|
|
2016
Q1 | $2.92M | Sell |
119,229
-3,031
| -2% | -$74.2K | ﹤0.01% | 2705 |
|
|
2015
Q4 | $4.04M | Buy |
122,260
+10,224
| +9% | +$338K | ﹤0.01% | 2558 |
|
|
2015
Q3 | $3.67M | Buy |
112,036
+99,615
| +802% | +$3.26M | ﹤0.01% | 2608 |
|
|
2015
Q2 | $658K | Buy |
12,421
+12,388
| +37,539% | +$656K | ﹤0.01% | 3615 |
|
|
2015
Q1 | $1K | Sell |
33
-567
| -95% | -$17.2K | ﹤0.01% | 5875 |
|
|
2014
Q4 | $17K | Sell |
600
-3,800
| -86% | -$108K | ﹤0.01% | 5254 |
|
|
2014
Q3 | $56K | Buy |
+4,400
| New | +$56K | ﹤0.01% | 4795 |
|